“…With kidney disease, there is a decrease in the clearance of prolactin, resulting in hyperproteinemia. Underlying comorbidities of autoimmune disease and use of immunosuppressive medications, like cyclophosphamide, to treat them also increase the risk of menstrual abnormalities (3). The reasons for the higher rates of menstrual abnormalities in women on peritoneal dialysis versus hemodialysis remain unclear, especially because patients on peritoneal dialysis likely have higher residual kidney function.…”